A nurse at a Johannesburg clinic turned away patients today after the U.S. government abruptly cut funding for life-saving HIV medications. In South Africa and Mozambique, community health programs that once relied on the PEPFAR program are now navigating a catastrophic collapse in global aid. According to NPR, these programs have been "heavily impacted" by the Trump administration's cuts, leaving over 10 percent of the Mozambican population at risk of losing access to treatment. Simultaneously, the U.S. administration is prioritizing a $1 billion White House luxury ballroom and a 250-foot golden Triumphal Arch in the capital.

While biological survival is rationed in the Global South, the Global North is institutionalizing a new metabolic divide. In France, Health Minister Stéphanie Rist announced that the country will become the first in the EU to provide permanent reimbursement for obesity drugs like Wegovy and Mounjaro. People in France currently pay around €300 a month out of pocket for these injections, which ScienceAlert reports are linked to lower risks of kidney disease and sleep apnea. The contrast is stark: the state secures physiological transcendence for the wealthy while amputating the medication supply of the poor.

Read together, the withdrawal of health aid from the global sick and the withdrawal of pay from domestic federal guards suggests a state that has abandoned its social contract. This paper's reading of these developments identifies a pattern of imperial triage, where the administration sacrifices its commitments to public health to fund the aesthetics of power. Per the latest filings, the U.S. Treasury continues to disburse billions in corporate tariff refunds while millions in the Global South face a logistical siege of their medical clinics.